100 related articles for article (PubMed ID: 24585397)
1. Stereomicroscopic imaging technique for the quantification of cold flow in drug-in-adhesive type of transdermal drug delivery systems.
Krishnaiah YS; Katragadda U; Khan MA
J Pharm Sci; 2014 May; 103(5):1433-42. PubMed ID: 24585397
[TBL] [Abstract][Full Text] [Related]
2. Cold flow of estradiol transdermal systems: influence of drug loss on the in vitro flux and drug transfer across human epidermis.
Krishnaiah YS; Yang Y; Hunt RL; Khan MA
Int J Pharm; 2014 Dec; 477(1-2):73-80. PubMed ID: 25311180
[TBL] [Abstract][Full Text] [Related]
3. Cold Flow Evaluation in Transdermal Drug Delivery Systems by Measuring the Width of the Oozed Adhesive.
Miyazaki T; Kanno H; Yamamoto E; Ando D; Izutsu KI; Goda Y
AAPS PharmSciTech; 2020 Apr; 21(4):120. PubMed ID: 32323091
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
[TBL] [Abstract][Full Text] [Related]
5. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
6. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
[TBL] [Abstract][Full Text] [Related]
7. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
[TBL] [Abstract][Full Text] [Related]
8. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
9. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
Goswami T; Audett J
Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
[TBL] [Abstract][Full Text] [Related]
10. Application of confocal laser scanning microscopy in characterization of chemical enhancers in drug-in-adhesive transdermal patches.
Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Hovgaard L; Frokjaer S
AAPS PharmSci; 2002; 4(1):E3. PubMed ID: 12049487
[TBL] [Abstract][Full Text] [Related]
11. Water-compatible cross-linked pyrrolidone acrylate pressure-sensitive adhesives with persistent adhesion for transdermal delivery: Synergistic effect of hydrogen bonding and electrostatic force.
Gong K; Sun P; Cai Y; Wang X; Pang Y; Liu C; Guo J; Fang L
Acta Biomater; 2024 Apr; 179():130-148. PubMed ID: 38460932
[TBL] [Abstract][Full Text] [Related]
12. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
[TBL] [Abstract][Full Text] [Related]
13. Release liner removal method for transdermal drug delivery systems (TDDS).
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
J Pharm Sci; 2010 Jul; 99(7):3177-87. PubMed ID: 20135693
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Drug Transfer Due to Drug Retention in Human Epidermis Pretreated with Application of Marketed Estradiol Transdermal Systems.
Krishnaiah YSR; Pavurala N; Yang Y; Manda P; Katragadda U; Yang Y; Shah R; Fang G; Khan MA
AAPS PharmSciTech; 2017 Aug; 18(6):2131-2140. PubMed ID: 28028793
[TBL] [Abstract][Full Text] [Related]
15. Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
Latsch S; Selzer T; Fink L; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):383-95. PubMed ID: 15019000
[TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Model for the Long-Term Stability Assessment of Drug-In-Adhesive Transdermal Films Using Polar Pressure-Sensitive Adhesives as Carrier/Matrix.
Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
J Pharm Sci; 2017 May; 106(5):1293-1301. PubMed ID: 28088456
[TBL] [Abstract][Full Text] [Related]
17. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Agrawal SS; Aggarwal A
Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
[TBL] [Abstract][Full Text] [Related]
18. Confocal Raman investigation of diffusion processes in monolithic type transdermal drug delivery systems.
Meyer S; Heinsohn G; Wolber R; Pörtner R; Nierle J
Drug Deliv; 2015 Dec; 22(8):1103-1110. PubMed ID: 24580682
[TBL] [Abstract][Full Text] [Related]
19. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
20. Pressure-sensitive adhesive properties of poly(N-vinyl pyrrolidone)/D,L-lactic acid oligomer/glycerol/water blends for TDDS.
Zhang J; Deng L; Zhao H; Liu M; Jin H; Li J; Dong A
J Biomater Sci Polym Ed; 2010; 21(1):1-15. PubMed ID: 20040150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
